Jaguar Health Completes Effectiveness Trial to Support FDA Approved Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
April 8, 2026
Health
-
-
Apollo Biowellness, Inc., Update of Take-Over by MedwellAI, Inc.
April 8, 2026
-
Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners
April 7, 2026
-
Inspira Technologies Announces Acquisition of the AME Platform from Nano Dimension
April 6, 2026
-
Venus Concept Announces Completion of Common Stock Sale and Short-Form Merger
April 1, 2026
-
Avalon Quantum AI Announces Strategic Collaboration with Caylent, an Amazon Web Services Premier Tier Partner, to Advance its Catch-Up Product into a Fully Autonomous Agentic AI Video Platform
March 31, 2026
-
Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
March 23, 2026
-
SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution
March 23, 2026
-
HealthWarehouse.com Reports Full Year 2025 Results
March 20, 2026
-
Co-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution Territory Across South Asia
March 20, 2026
-
OneMedNet and Navidence Announce Strategic Collaboration: Empowering Pharma with Precision Real-World Data Insights
March 18, 2026
-
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity
March 18, 2026
-
Cumberland Pharmaceuticals Launches New Sancuso® Website Featuring Educational Resources for Chemotherapy-Induced Nausea and Vomiting
March 17, 2026
-
Flyte Launches Florida Hops to Service Accelerating Demand
March 16, 2026
-
Vicarious Surgical Announces Strategic Plan to Pursue Nasdaq Listing
March 16, 2026
-
NEXGEL Announces Consideration Terms of Agreement to License and Acquire Portfolio of Commercial-Stage Regenerative Biomaterial Products
March 12, 2026